XPO1 and acute myeloid leukemia: It not only demonstrated in vitro the ability to form a covalent linkage with Cys275 in certain AML NPM1 mutants (types A and E) but also inhibited the nuclear export of the XPO1 protein, altering NPM1’s cellular localization and partially relocating NPM1c+ to the nucleus [86].